Biospeedia offers bespoke assay development services that range from a simple assay-feasibility project to a full-scale development project. Our location at the Institut Pasteur campus in Paris and our strategic and industrial partnerships across the world give us access to state-of-the-art facilities and high quality resources (antibodies, antigens, reagents, ...)
We develop innovative and performing Rapid Diagnostic Tests for infectious diseases such as meningitis (Streptococcus pneumonia, Neisseria meningitidis), dengue, malaria, typhoid, filariosis...
Our Rapid Tests are robust and easy-to-use by everyone (health professionals or not), in order to make faster and accurate lifesaving decisions in any circumstances or locations.
BioSpeedia develops and manufactures an innovative range of enzyme-linked immunosorbent assay (ELISA) kits for the qualitative detection of targeted proteins and molecules, in various assay formats including sandwich or competitive ELISA kits.
All the reagents are designed to be of high-quality, high-performance and high-accuracy.
We provide a complete range of immunochromatographic assays intended for the qualitative detection of different drugs and drug metabolites in human fluids (urine and saliva).
Combining our in-house technologies, BioSpeedia also has significantly improved the cut-off detection level of several drugs by applying the same technology and accuracy developed for our human infectious diseases Rapid Diagnostic Tests.
“Halal” means "permitted" in arabic and is mostly used to designate food that is allowed for consumption.
Whether it is for religous believes, lifestyles (vegan diets, veganism,..) or allergies, everybody has the right to know what they eat.
Our Halal Tests range goal is to help people and industries to detect pork traces and pork derivates in food (i.e. gelatin) or on equipment.
Human health also relies on animal health.
At BioSpeedia, we aim at providing Rapid Tests for veterinary and agriculture industries to help with fast and accurate diagnostic of targeted diseases potentially affecting animals.
Evelyne Bégaud, is a graduate of the Institut Pasteur. She has a PhD in Pharmaceutical Sciences (Microbiology and Ecology). For more than 20 years, Evelyne worked in the Institut Pasteur International Network on infectious diseases.
Yves Germani, is a graduate of the Institut Pasteur. He has a PhD in Pharmaceutical Sciences (Microbiology and Ecology) and a PhD in Natural Sciences (Immunology and Genetics). Yves was qualified as Professor of Cell & Molecular Biology in 2004.
25 rue du Docteur Roux
Tel. 00 33 (0) 1 40 61 37 20 (Headquarters)
Fax. 00 33 (0) 1 40 59 99 04